Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa
Clinical trial NCT02304406 · COMPLETED
Trial details
- NCT number
- NCT02304406
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-01-21
- Primary completion
- 2018-02-11
- Enrollment
- 449
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.